Product Information
PAROXETINE ER 25 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.3856 per EA under NDC 62175047132. Its NADAC has been published 525 times since Sep 14, 2016.
FDA first approved this application on Jun 10, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Lannett Company Inc.NDC
62175047132
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204744FDA Approved
6/10/2016
TE Code
AB
On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 25 MG TABLET has been published 525 times since Sep 14, 2016, and over the history we have for it it has declined 91.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3856 per EA |
|---|---|
| All-time high | $4.4733 (Oct 12, 2016) |
| All-time low | $0.3584 (Nov 20, 2024) |
| 52-week high | $0.5084 |
| 52-week low | $0.3809 |
| Median price | $1.0063 |
| Average price | $1.4557 |
| Largest weekly change | +53.5% (Jul 19, 2023) |
| Weeks tracked | 525 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Paroxetine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paroxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 25 MG TABLET, manufactured by Lannett Company Inc., is $0.3856 per EA (NDC 62175047132), effective Sep 30, 2026.
How has the price of PAROXETINE ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 25 MG TABLET has declined 91.4%. It has been tracked across 525 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 25 MG TABLET?
Since Sep 14, 2016, the NADAC for PAROXETINE ER 25 MG TABLET has ranged from a low of $0.3584 (Nov 20, 2024) to a high of $4.4733 (Oct 12, 2016), with a median of $1.0063 per EA.
Are there cheaper alternatives to PAROXETINE ER 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE ER 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 25 MG TABLET?
PAROXETINE ER 25 MG TABLET (NDC 62175047132) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.